1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Cirrhoses, Liver: new trials by email Literature Review of Cirrhoses, Liver trials Research Report on Cirrhoses, Liver
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b Elbasvir/ Grazoprevir 50/100 mg fixed dose combination - Chronic Hepatitis C Genotype 1B, Metabolic Syndrome | Phase 3 | Unknown | Institute Of Cardiology & Internal Diseases, Kazakhstan | 60 | 2017-10-01 | 2017-08-07 |
Hepatitis C (1) · Liver Cirrhosis (1) · Metabolic Syndrome (1)
Blood-Borne Infections (1) · Communicable Diseases (1) · Digestive System Diseases (1) · Fibrosis (1) · Flaviviridae Infections (1) · Glucose Metabolism Disorders (1) · Hepatitis (1) · Hepatitis, Viral, Human (1) · Hyperinsulinism (1) · Infections (1) · Insulin Resistance (1) · Liver Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1)
elbasvir (1) · grazoprevir (1)
Institute Of Cardiology & Internal Diseases, Kazakhstan (1)
Kazakhstan (1)